Virus News and Research

Latest Virus News and Research

Nanomedicines prevent tissue damage associated with atherosclerosis, other chronic diseases

Doses of medicine 100,000 times smaller than the diameter of a human hair prevent the tissue damage associated with atherosclerosis and other chronic diseases in mice.

20 Mar 2013

Research findings could lead to development of new drugs for gout treatment

Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout.

20 Mar 2013

Viewpoints: Protect the FDA's regulatory efforts; Generic drug 'shenanigans;' Does Ryan not understand the 2012 election?

On Tuesday, the Supreme Court will hear arguments in Mutual Pharmaceutical v. Bartlett, a case about the ability of consumers to bring lawsuits against the makers of generic drugs.

20 Mar 2013

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.

19 Mar 2013

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Individuals infected by the hepatitis C virus (HCV) have nothing to fear from sex in a monogamous, heterosexual relationship. Transmission of HCV from an infected partner during sex is rare according to new research published in the March issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD).

19 Mar 2013

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

19 Mar 2013

A Map of 'Shortcuts' simplifies the hunt for disease-causing genes

Some diseases are caused by single gene mutations. Current techniques for identifying the disease-causing gene in a patient produce hundreds of potential gene candidates, making it difficult for scientists to pinpoint the single causative gene.

19 Mar 2013

Study shows widespread use of antiretroviral drugs would increase prevalence of MDR HIV

One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men in LA County over the next 10 years, cautions a new study.

19 Mar 2013

Oral Cancer Foundation encourages dental practices to offer free oral cancer screenings in April

What has the greatest impact on survival rates of oral cancer? Radiation? Chemotherapy? Perhaps surgery? The truth is none of these; rather, it is the point in time at which the disease is discovered.

18 Mar 2013

2 in 5 parents believe HPV vaccine is unnecessary

A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo Clinic and others shows.

18 Mar 2013

UCLA researchers predict hotspots for future outbreaks of influenza virus

This year's unusually long and rocky flu season would be nothing compared to the pandemic that could occur if bird flu became highly contagious among humans, which is why UCLA researchers and their colleagues are creating new ways to predict where an outbreak could emerge.

17 Mar 2013

Cytomegalovirus employs a novel trick to hide from immune detection

A virus that most people have probably never heard of, yet most of us carry, is the number 1 infectious cause of congenital birth defects. One in 750 children are born with, or develop, permanent disabilities such as hearing loss or brain damage as a result of CMV (cytomegalovirus) infection in the womb.

17 Mar 2013

Small percentage of adults who receive rapid HIV treatment following infection might achieve 'functional cure,' French researchers say

"Rapid treatment after HIV infection may be enough to 'functionally cure' about a 10th of those diagnosed early, say researchers in France," who "have been analyzing 14 people who stopped therapy, but have since shown no signs of the virus resurging," BBC News reports (Gallagher, 3/15).

16 Mar 2013

Study: Novel strategy could lead to universal influenza vaccine that can provide long-lasting protection

Seasonal epidemics of influenza result in nearly 36,000 deaths annually in the United States, according to the Centers for Disease Control. Current vaccines against the influenza virus elicit an antibody response specific for proteins on the outside of the virus, specifically the hemagglutinin protein.

15 Mar 2013

Researchers identify enzymes that activate coronavirus for infection

Scientists all over the world are on a quest for an antidote since the first patient died from the new coronavirus in summer 2012. Infection Researchers from the German Primate Center have now identified enzymes that activate the virus for infection.

15 Mar 2013

New therapeutic approach for bladder pain syndrome

Severe chronic pain associated with conditions such as bladder pain syndrome/interstitial cystitis often require the use of opioid medication, with the risk of dependency and serious adverse reactions.

15 Mar 2013

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch (UTMB).

15 Mar 2013

WHO reports 9th death from new SARS-like virus

"A Saudi man infected with a deadly new virus from the same family as SARS has died, becoming the ninth patient in the world to be killed by the disease which has so far infected 15, the World Health Organization said on Tuesday," Reuters reports.

14 Mar 2013

Research finding aids efforts toward cytomegalovirus vaccine

A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero development, 1 in 750 children are born with or develop permanent disabilities such as hearing loss or brain damage.

14 Mar 2013

Peter Piot to be recognized with Hideyo Noguchi Africa Prize for Medical Research

Professor Peter Piot, Director of the London School of Hygiene & Tropical Medicine, will be awarded the Hideyo Noguchi Africa Prize for Medical Research, the Government of Japan have announced.

14 Mar 2013

Virus News and Research

Latest Virus News and Research

Nanomedicines prevent tissue damage associated with atherosclerosis, other chronic diseases

Research findings could lead to development of new drugs for gout treatment

Viewpoints: Protect the FDA's regulatory efforts; Generic drug 'shenanigans;' Does Ryan not understand the 2012 election?

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

A Map of 'Shortcuts' simplifies the hunt for disease-causing genes

Study shows widespread use of antiretroviral drugs would increase prevalence of MDR HIV

Oral Cancer Foundation encourages dental practices to offer free oral cancer screenings in April

2 in 5 parents believe HPV vaccine is unnecessary

UCLA researchers predict hotspots for future outbreaks of influenza virus

Cytomegalovirus employs a novel trick to hide from immune detection

Small percentage of adults who receive rapid HIV treatment following infection might achieve 'functional cure,' French researchers say

Study: Novel strategy could lead to universal influenza vaccine that can provide long-lasting protection

Researchers identify enzymes that activate coronavirus for infection

New therapeutic approach for bladder pain syndrome

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

WHO reports 9th death from new SARS-like virus

Research finding aids efforts toward cytomegalovirus vaccine

Peter Piot to be recognized with Hideyo Noguchi Africa Prize for Medical Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in